Document is current
Any future updates will be listed below
-
Authors
Schwarz, Anne https://orcid.org/0000-0001-8943-5673
Song, Min-Keun https://orcid.org/0000-0001-8186-5345
Wu, Ming
Sakthi, Shivani
Settle, Maeve
Farahmand, Eden
Wing, Rachel
Hansen, Matthew
Veerbeek, Janne Marieke https://orcid.org/0000-0002-6337-6780
Cramer, Steven C. https://orcid.org/0000-0002-6214-6211
- License Information
-
More Information
Article History
Received: 26 September 2025
Accepted: 8 July 2026
First Online: 8 August 2026
Declarations
Ethics approval and consent to participate: Not applicable.
Consent for publication: Not applicable.
Competing interests: SCC serves as a consultant for Astellas, Alevian, Bayer, BlueRock Therapeutics, BrainQ, Constant Therapeutics, Medtronic, MicroTransponder, Myomo, Myrobalan, NeuroTrauma Sciences, Simcere, and TRCare. AS, MKS, MW, EF, MS, SS, MH, RW, and JMV have no competing interests to declare.
